Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients Publication Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…CertaraJuly 29, 2026
Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification Poster Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…CertaraJuly 24, 2026
Important drug development questions that model-based meta-analysis answers Blog Important drug development questions that model-based meta-analysis answers Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…Matt Zierhut, PhD MBAJuly 23, 2026
A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans Poster A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…CertaraJuly 20, 2026
From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development On-Demand Webinar From Dosimetry to Dose Decisions: How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development Learn how dosimetry, clinical pharmacology, pharmacometrics, QSP, and regulatory strategy support dose optimization for therapeutic…Hunter Stephens, PhDJuly 17, 2026
Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis Publication Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…CertaraJuly 16, 2026
Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia Publication Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer’s dementia Explore how population pharmacokinetic and exposure–response modeling informed brexpiprazole dosing in Japanese patients with agitation…CertaraJuly 16, 2026
Enhanced Bioavailability of a Novel Oil-Based Lutein Formulation: A Randomized, Double-Blind, Single-Dose, Comparative Oral Bioavailability Study in Healthy Adults Publication Enhanced Bioavailability of a Novel Oil-Based Lutein Formulation: A Randomized, Double-Blind, Single-Dose, Comparative Oral Bioavailability Study in Healthy Adults See how a randomized, double-blind study proved enhanced bioavailability of a novel oil-based lutein formulation,…CertaraJuly 14, 2026